Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma
出版年份 2013 全文链接
标题
Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 108, Issue 4, Pages 826-830
出版商
Springer Nature
发表日期
2013-02-15
DOI
10.1038/bjc.2013.46
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
- (2012) A. Naing et al. CLINICAL CANCER RESEARCH
- The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells
- (2012) Maria Cristina De Martino et al. ENDOCRINE-RELATED CANCER
- Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
- (2012) Matthias Kroiss et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adrenocortical stem and progenitor cells: Implications for adrenocortical carcinoma
- (2012) Derek P. Simon et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Combination Chemotherapy in Advanced Adrenocortical Carcinoma
- (2012) Martin Fassnacht et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer
- (2011) Aung Naing et al. CLINICAL CANCER RESEARCH
- Targeted Therapies for Adrenocortical Carcinoma: IGF and Beyond
- (2011) Michael J. Demeure et al. Hormones & Cancer
- Regulation of Insulin-like Growth Factor–Mammalian Target of Rapamycin Signaling by MicroRNA in Childhood Adrenocortical Tumors
- (2010) Mabrouka Doghman et al. CANCER RESEARCH
- Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane
- (2009) Elizabeth G. Grubbs et al. ANNALS OF SURGICAL ONCOLOGY
- Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
- (2009) Paul Haluska et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Prevalence and Incidence of Endocrine and Metabolic Disorders in the United States: A Comprehensive Review
- (2009) Sherita H. Golden et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma
- (2008) Martin Fassnacht et al. CANCER
- Expression of Insulin-Like Growth Factor-II and Its Receptor in Pediatric and Adult Adrenocortical Tumors
- (2008) Madson Q. Almeida et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma
- (2008) Ferdous M. Barlaskar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started